Activity of a novel sulfonamide compound 2-nitro-N-(pyridin-2-ylmethyl)benzenesulfonamide against Leishmania donovani

New treatments for visceral leishmaniasis, caused by Leishmania donovani, are needed to overcome sustained toxicity, cost, and drug resistance. The aim of this study was to evaluate the therapeutic effects of 2-nitro-N-(pyridin-2-ylmethyl)benzenesulfonamide (2NB) against promastigote and amastigote...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Drug Des Devel Ther
Prif Awduron: Dikhit, Manas R, Purkait, Bidyut, Singh, Ruby, Sahoo, Bikash Ranjan, Kumar, Ashish, Kar, Rajiv K, Ansari, Md Yousuf, Saini, Savita, Abhishek, Kumar, Sahoo, Ganesh C, Das, Sushmita, Das, Pradeep
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Dove Medical Press 2016
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4887065/
https://ncbi.nlm.nih.gov/pubmed/27307706
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S96650
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg